CVS Health (CVS) EBITDA (2008 - 2026)
CVS Health (CVS) EBITDA from Jun 28, 2008 to Mar 31, 2026. The TTM CVS Health (CVS) EBITDA is $11B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
CVS Health (CVS) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -25.99% |
| 3 Years TTM | -4.34% |
| 5 Years TTM | -10.66% |
| 10 Years TTM | -1.08% |
| All Time TTM | +7.78% |
Annual EBITDA change of CVS Health (CVS)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $5.79B | -37.46% |
| 2025 | $9.27B | -29.34% |
| 2024 | $13B | -27.59% |
| 2023 | $18B | +48.70% |
| 2022 | $12B | -31.57% |
| 2021 | $18B | -3.03% |
| 2020 | $18B | +12.19% |
| 2019 | $16B | +142.74% |
| 2018 | $6.74B | -43.92% |
| 2017 | $12B | +119.49% |
| 2016 | $5.47B | -52.67% |
| 2015 | $12B | +7.80% |
| 2014 | $11B | +8.31% |
| 2013 | $9.91B | +10.53% |
| 2012 | $8.96B | +13.47% |
| 2011 | $7.90B | +3.85% |
| 2010 | $7.61B | -2.66% |
| 2009 | $7.81B | +6.75% |
| 2008 | $7.32B | +24.30% |
| 2007 | $5.89B | N/A |
Comparison CVS Health (CVS) five years EBITDA CAGR with competitors
CVS Health (CVS) five years EBITDA CAGR is -10.66%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PGNY | Progyny Inc | 41.25% | -486.84% |
| CI | Cigna Group (The) | 2.56% | -124.01% |